Charles J. Homcy - 19 Nov 2025 Form 4 Insider Report for Maze Therapeutics, Inc. (MAZE)

Reporting relationship: Director
Issuer ticker: MAZE
Reported as of: 19 Nov 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Nov 2025, 16:24:47 UTC
Prior SEC filing: 27 Oct 2025
Next SEC filing: 06 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Courtney Phillips, as attorney-in-fact

Key filing fact

Charles J. Homcy filed Form 4 for Maze Therapeutics, Inc. (MAZE) on 21 Nov 2025.

Key facts

This page summarizes Charles J. Homcy's Form 4 filing for Maze Therapeutics, Inc. (MAZE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Nov 2025, 16:24.

Change

Previous filing in this sequence was filed on 27 Oct 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001192591 Primary reporting owner

HOMCY CHARLES J

Relationship: Director
Address: C/O MAZE THERAPEUTICS, INC., 171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Signature: /s/ Courtney Phillips, as attorney-in-fact
Signature date: 21 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MAZE transaction

Common Stock

Other

Transaction value: $0
Shares: +1,489
Change %: +5%
Price: $0.000000
Shares after: 31,113
Date: 19 Nov 2025
Ownership: Direct
Footnotes: F1

MAZE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,422
Date: 19 Nov 2025
Ownership: By Trust
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported transaction represents the receipt by the reporting person of his pro rata share of a distribution made by one or more entities affiliated with Third Rock Ventures, for no consideration, of shares of the Issuer's common stock, which distribution was made in accordance with the exemption afforded by Rule 16a-9 of the Securities Exchange Act of 1934, as amended.

Footnote F2

These securities are directly held by the Charles J. Homcy Revocable Trust UA 11/4/1998, of which the reporting person is the trustee.